Enrique Grande, Director of the Medical Oncology Department at Quirónsalud, and Adjunct Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:
“[18F]RCCB6 PET/CT in clear cell RCC:
- Sensitivity: 94.2%
- Accuracy: 93.1%
- Positive Predictive Value (PPV): 98.3%
Comparison with [18F]FDG PET/CT:
- Sensitivity: 90.5% vs. 41.1%
- Specificity: 81.4% vs. 24.3%
And it changed clinical management in 58.7% of patients.
CD70-targeted imaging may finally give ccRCC the PET tracer it deserves.”
Title: [18F]RCCB6 PET/CT in Diagnosing Clear Cell Renal Cell Carcinomas: A Prospective Comparison Study with [18F]FDG PET/CT and Conventional Imaging
Authors: Qianyun Wu, Shuxian An, Fabrizia Gelardi, You Zhang, Lianghua Li, Wen Kong, Min Cao, Wenzhi Jia, Dongsheng Xu, Liangrong Wan, Gan Huang, Cheng Wang, Zhoumi Hu, Jiwei Huang, Wei Zhai, Jin Zhang, Arturo Chiti, Gang Huang, Jianjun Liu, Weijun Wei
Other articles featuring Enrique Grande on OncoDaily.